Compounds > arbekacin

arbekacin and tigecycline

arbekacin has been researched along with tigecycline in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aggen, JB; Armstrong, ES; Bonomo, RA; Choudhary, Y; Endimiani, A; Hujer, AM; Hujer, KM	1
LaPlante, KL; Rybak, MJ	1
Chin, JN; LaPlante, KL; Leuthner, KD; Rybak, MJ	1
Cho, H; Chung, NG; Han, SB; Park, KG; Park, YJ	1

Other Studies

4 other study(ies) available for arbekacin and tigecycline

Article	Year
ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10 Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Structure	2009
Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline. Diagnostic microbiology and infectious disease, 2004, Volume: 50, Issue:2 Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Minocycline; Probability; Sampling Studies; Sensitivity and Specificity; Staphylococcus; Tigecycline; Vancomycin	2004
Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:4 Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Dibekacin; Enterococcus faecalis; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline	2006
First Case of Skin and Soft Tissue Infection Caused by Mycoplasma hominis in a Pediatric Immunocompromised Patient. Annals of laboratory medicine, 2017, Volume: 37, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Dibekacin; DNA, Bacterial; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Mycoplasma hominis; Mycoplasma Infections; Polymerase Chain Reaction; Soft Tissue Infections; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tigecycline; Transplantation, Homologous	2017